The study, sponsored by Indiana University, aims to develop a miniaturized smart sensor device capable of noninvasively detecting hypo- and hyperglycemic events in diabetic patients through the analysis of VOCs in exhaled breath. This innovative approach could potentially disrupt the diabetes management market by providing a non-invasive alternative to traditional blood glucose monitoring methods. The target demographic includes children and young adults aged 7-25 with Type 1 and Type 2 diabetes, a segment that represents a significant portion of the diabetes population. If successful, this technology could enhance patient compliance and improve glycemic control, thereby addressing a critical need in diabetes care. The competitive landscape includes established continuous glucose monitoring (CGM) systems, but the non-invasive nature of this device may offer a unique selling proposition. Diligence should focus on regulatory pathways, potential partnerships for commercialization, and the scalability of manufacturing the sensor device.